Interferon and its inducers - A never-ending story: "Old" and "new" data in a new perspective
Interferon and its inducers - A never-ending story: "Old" and "new" data in a new perspective
复制标题
DOI:
10.1086/505351
复制
发表时间:
2006-09-15
影响因子:
6.4
通讯作者:
De Clercq, Erik
中科院分区:
文献类型:
--
作者:
De Clercq, Erik
The discovery of interferon (IFN), as an antiviral substance, by Isaacs and Lindenmann in 1957 [1] attracted the attention of a number of investigators, including Pieter De Somer at the Rega Institute in Leuven (Belgium) and Tom Merigan at Stanford University (California). De Somer’s original attempts were aimed at determining the mode of action of IFN [2], whereas Merigan’s work focused on trying to understand the role of IFN in human viral diseases [3], by use of the mouse as an animal model. Of pioneering importance was the demonstration by Merigan [4] in 1967 that IFN could be induced in mice by a synthetic polyanion called maleic divinyl ether copolymer (or pyran copolymer). In further experiments, pyran copolymer was also shown to induce IFN in humans [5], although the serum IFN titers obtained in humans were considerably lower than those in mice and, moreover, were accompanied by a considerable increase in body temperature. Meanwhile, in De Somer’s laboratory, I had identified 2 other polyanions, polyacrylic acid (PAA) and polymethacrylic acid, as antiviral agents [6, 7] and attributed their antiviral action to either the induction of IFN or a direct interference with virus adsorption to the cells. Overall, the structures of PAA and polymethacrylic acid are quite similar to that of pyran copolymer (figure 1), the prominent features being the-CCCCCC-or-CCCOCC-backbone and the negatively charged carboxylic acids mounted on this backbone.